- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
258
6 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
258 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$173.95 | -1.2% | 59.0% | US$55.3b | US$174.38 | PE81.2x | E46.3% | 2.1% | Diversified Financials | ||
ALNY | US$253.01 | 0.8% | 46.4% | US$32.6b | US$298.77 | PS15.6x | E70.3% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$58.53 | 0.1% | 96.2% | US$18.7b | US$59.72 | PE131.8x | E29.6% | n/a | Consumer Durables | ||
NVDA | US$138.63 | 1.9% | 204.6% | US$3.4t | US$171.12 | PE53.8x | E25.1% | 0.03% | Semiconductors | ||
SRPT | US$127.95 | 11.6% | 48.6% | US$12.7b | US$183.60 | PE100.3x | E42.5% | n/a | Pharmaceuticals & Biotech | ||
NU | US$12.00 | -15.7% | 46.7% | US$60.2b | US$15.74 | PB7.5x | E28.9% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BX | US$187.05 | -3.1% | 61.9% | US$233.4b | US$169.80 | PE64.6x | E27.9% | 1.8% | Diversified Financials | ||
KSPI | US$106.17 | -0.02% | 10.6% | US$20.2b | US$133.84 | PE10.7x | E23.7% | 6.2% | Diversified Financials | ||
SMCI | US$42.00 | 9.3% | 57.7% | US$19.1b | US$40.32 | PE20.4x | E24.3% | n/a | Tech | ||
OWL | US$23.04 | -5.5% | 72.7% | US$35.4b | US$23.58 | PE122.5x | E59.2% | 3.1% | Diversified Financials | ||
DUOL | US$346.52 | -0.4% | 59.7% | US$15.3b | US$327.23 | PE175.6x | E41.6% | n/a | Consumer Services | ||
DASH | US$176.37 | -1.5% | 79.3% | US$75.0b | US$173.38 | PS7.2x | E56.0% | n/a | Consumer Services | ||
TER | US$113.20 | 2.3% | 21.5% | US$17.9b | US$134.62 | PE35.9x | E21.7% | 0.4% | Semiconductors | ||
RYAN | US$74.04 | -0.7% | 63.2% | US$19.7b | US$73.98 | PE91.1x | E44.5% | 0.6% | Insurance | ||
NTNX | US$66.15 | -9.1% | 48.7% | US$17.5b | US$81.82 | PS7.9x | E90.6% | n/a | Software | ||
SN | US$98.33 | -4.3% | 110.8% | US$14.1b | US$121.69 | PE38.4x | E22.8% | n/a | Consumer Durables | ||
EXE | US$97.84 | -1.0% | 24.9% | US$22.9b | US$104.75 | PE89x | E93.3% | 2.5% | Energy | ||
VRT | US$127.05 | -3.8% | 180.1% | US$47.9b | US$141.42 | PE82x | E31.2% | 0.1% | Capital Goods | ||
CVNA | US$254.94 | -2.2% | 536.2% | US$55.0b | US$246.31 | PE1927.2x | E44.9% | n/a | Retail | ||
SPOT | US$480.27 | -0.2% | 147.3% | US$96.4b | US$473.55 | PE131.8x | E29.6% | n/a | Media | ||
XPEV | US$12.69 | 9.2% | -20.8% | US$11.4b | US$14.48 | PS2.3x | E63.9% | n/a | Automobiles | ||
CTRA | US$26.09 | -3.3% | 1.2% | US$19.7b | US$32.90 | PE15.5x | E30.2% | 3.2% | Energy | ||
ZS | US$208.51 | -0.9% | 5.2% | US$31.7b | US$220.15 | PS14.8x | E39.3% | n/a | Software |